Seizinger Bernd R. — SEC Form 4 filings
SEC reporting owner CIK 1789042. 10 Form 4 filings on record with FilingPulse; latest filed 2026-07-02.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-02-07 to 2026-07-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 5 legs across 4 filings — 216,860 shares, $264,033 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 14.
- Largest priced transaction: purchase of 100,000 shares @ $1.04 ($103,770) in ONCOLYTICS BIOTECH INC, filed 2026-01-20.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ONCOLYTICS BIOTECH INC (ONCY) | Director | 3 | 3 legs · 200,000 sh · $187,224 | — | 1 |
| Aprea Therapeutics, Inc. (APRE) | Director | 5 | 2 legs · 16,860 sh · $76,809 | — | 8 |
| Aptose Biosciences Inc. (APTO) | — | 2 | — | — | 5 |
Form 4 filings — Seizinger Bernd R.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-02 | 4 | Aptose Biosciences Inc. (APTO) | Disposition to issuer (D): 17,000 @ $1.72 · Disposition to issuer (D): 3,333 (derivative) @ $0 · Disposition to issuer (D): 100,000 (derivative) @ $0 · Disposition to issuer (D): 50,000 (derivative) @ $0 | EDGAR |
| 2026-06-17 | 4 | Aprea Therapeutics, Inc. (APRE) | Grant/award (A): 3,135 @ $0 · Grant/award (A): 12,555 (derivative) @ $0 | EDGAR |
| 2026-06-03 | 4 | ONCOLYTICS BIOTECH INC (ONCY) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | ONCOLYTICS BIOTECH INC (ONCY) | Purchase (P): 60,000 @ $0.83 · Purchase (P): 40,000 @ $0.85 | EDGAR |
| 2026-01-20 | 4 | ONCOLYTICS BIOTECH INC (ONCY) | Purchase (P): 100,000 @ $1.04 | EDGAR |
| 2025-06-09 | 4 | Aprea Therapeutics, Inc. (APRE) | Grant/award (A): 1,045 @ $0 · Grant/award (A): 4,185 (derivative) @ $0 | EDGAR |
| 2024-10-15 | 4 | Aprea Therapeutics, Inc. (APRE) | Purchase (P): 10,000 @ $2.68 | EDGAR |
| 2024-06-21 | 4 | Aprea Therapeutics, Inc. (APRE) | Grant/award (A): 1,045 @ $0 · Grant/award (A): 4,185 (derivative) @ $0 | EDGAR |
| 2024-03-14 | 4 | Aprea Therapeutics, Inc. (APRE) | Purchase (P): 6,860 @ $7.29 · Purchase (P): 3,430 (derivative) · Purchase (P): 3,430 (derivative) | EDGAR |
| 2024-02-07 | 4 | Aptose Biosciences Inc. (APTO) | Grant/award (A): 3,333 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1789042 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →